Introduction
============

In 1990, Ellington and Szostak as well as Tuerk and Gold independently described SELEX (systematic evolution of ligands by exponential enrichment) --- a method to select aptamers.[@R1]^-^[@R3] Aptamers are small oligonucleotides that bind target molecules with high affinity and specificity. During the past two decades numerous aptamers have been selected for a huge variety of targets ranging from small molecules like fluorophores[@R4] to whole cells[@R5] or organisms.[@R6] Aptamers are now of great interest in fields such as diagnostics, therapeutics, biosensing or gene silencing.

Aptamer specificity reflects their three-dimensional structure, the specific arrangement of loops and stems and the hydrogen bonds that stabilize the structure. In guanine-rich aptamers, there are many examples of the slightly less common motif, the G-quadruplex. This consists of layers, each with four guanine nucleotides, held together by Hoogsteen hydrogen bonds and coordinated monovalent cations. G-quadruplexes occur naturally in telomers as well as in promoter regions.[@R7]^-^[@R10]

Several putative quadruplex-forming DNA and RNA aptamers for therapeutically relevant target molecules have been described, e.g., the thrombin binding DNA aptamer (TBA),[@R11] an RNA aptamer (GGA)~4~ specific for bovine prion protein[@R12]^,^[@R13] and the ethanolamine binding DNA aptamer.[@R14] Recently, we selected AIR-3A,[@R15] an G-quadruplex forming RNA aptamer with specificity for the interleukin-6-receptor (IL-6R). Other G-quadruplex-forming aptamers are already in clinical trials. Among these are the nucleolin-binding aptamer AS1411 for acute myeloid leukemia and renal cell carcinoma,[@R16] which is composed of two DNA oligonucleotides, and Zintevir an aptamer neutralising HIV infection.[@R17] Zintevir (also known as T30177, [Table 1](#T1){ref-type="table"}) has the sequence 5′-G\*TGGTGGGTGGGTGGG\*T-3′. In this case, the insertion of two internucleoside phosphorothioates (G\*) led to reduced degradation without influencing its inhibitory effect.[@R18] Zintevir, as well as its unmodified counterpart T30175 (5′-GTGGTGGGTGGGTGGGT-3′), belong to a group of HIV inhibitors, consisting of only desoxy-guanosines and --thymidines.[@R19] Another derivative of Zintevir with an equal antiviral effect is the structurally more stable inhibitor, T30695 (5′-G\*GGTGGGTGGGTGGG\*T-3′) as well as its unmodified version, referred to as T30923.[@R17]^,^[@R20] T30695 and T30923 are composed of a remarkable repetitive nucleotide motif: d(GGGT)~4~. Surprisingly, two different structures have been reported for d(GGGT)~4~. On the basis of CD spectroscopy and electrospray ionization mass spectrometry, it has been suggested that d(GGGT)~4~ forms a parallel-stranded quadruplex with three tetrads in which all guanines are involved ([Fig. 1](#F1){ref-type="fig"}).[@R18]^,^[@R21] In contrast, NMR data with molecular modeling led to an anti-parallel-stranded quadruplex structure[@R22] with two guanine tetrads. Both structures have in common that coordination of monovalent cations like potassium stabilizes the quadruplex structure.

###### **Table 1.** HIV inhibitors

  G-quadruplex                  Sequence (5′-3′)
  ----------------------------- -----------------------
  T30177 = Zintevir = AR177     G\*TGGTGGGTGGGTGGG\*T
  T30175                        GTGGTGGGTGGGTGGGT
  T30695                        G\*GGTGGGTGGGTGGG\*T
  T30923 = d(GGGT)~4~ = AID-1   GGGTGGGTGGGTGGGT

G\* = internucleoside phosphorothioates

![**Figure 1.** Putative G-quadruplex structure of AID-1. Scheme of parallel-stranded G-quadruplex topology[@R21]^,^[@R52] with nucleotides consecutively numbered. G1 represents the 5′-end and T16 the 3′-end, respectively.](rna-10-216-g1){#F1}

The inhibitory effect of Zintevir was initially attributed to its inhibition of HIV-1 integrase 3′ processing activity,[@R17] but HIV gp120 was later identified as the primary target thus preventing interaction with the CD4 receptor, which is essential for HIV infection.[@R23]

We report here on the selection of IL-6R specific aptamers. The multifunctional cytokine interleukin 6 (IL-6) and its receptor IL-6R are attractive targets for therapeutic agents as they are associated with diverse diseases such as osteoporosis and rheumatoid arthritis. They are also involved in inflammatory responses as well as in regulation of endocrinal or metabolic mechanisms.[@R24] The G-quadruplex-forming DNA aptamers selected in this study do not interfere with IL-6/IL-6R interaction. One of these DNA aptamers, AID-1, turned out to have exactly the same sequence \[d(GGGT)~4~\] and activity as the HIV-1 inhibitor T30923 mentioned above.

We identified aptamer variants, which affected binding to IL-6R and investigated the effect on quadruplex structure. We then examined the inhibitory effect of IL-6R aptamers and variants with retained or lost quadruplex structure on both HIV integrase activity as well as on HIV infection. Additionally, we tested the RNA aptamer AIR-3A and the RNA counterpart of d(GGGT)~4~ to this regard.

Results
=======

Selection and identification of DNA aptamers with affinity for the soluble human IL-6 receptor (sIL-6R)
-------------------------------------------------------------------------------------------------------

After 13 rounds of in vitro selection, five DNA aptamers were identified that recognized sIL-6R. All shared a conserved stretch of 16 nucleotides: 5′-GGGTGGG(T/C)GGGTGGG(T/A)-3′. These guanine-rich DNA aptamers bound sIL-6R with high affinity and binding constants in the low micromolar range ([**Table S1**](#SUP1){ref-type="supplementary-material"}). In addition, the interaction of IL-6R with the cytokine IL-6 and the signal transducer gp130 in the presence of bound AID-27 was analyzed by FRA. Neither the interaction of IL-6R with the cytokine IL-6 nor with gp130 was influenced by bound AID-27 ([**Fig. S1**](#SUP1){ref-type="supplementary-material"}).

The aptamer AID-27 was shortened from both ends to yield AID-1 comprising the conserved 16-base motif d(GGGT)~4~. Its interactions with its original target (sIL-6R) as well as with the designer cytokine "Hyper-IL-6"[@R27] were further characterized. Hyper-IL-6 is a fusion protein consisting of sIL-6R and the cytokine IL-6 covalently connected by a poly(Gly-Ser) linker. AID-1 showed a high affinity for Hyper-IL-6 with a *K*~d~ of 209 nM ([Fig. 2](#F2){ref-type="fig"}). A control FRA measurement with IL-6, thrombin and lysozyme showed no non-specific binding ([**Fig. S2**](#SUP1){ref-type="supplementary-material"}).

![**Figure 2.** IL-6 receptor specific aptamers and variants. (**A**) AID-1, rAID-1, AIR-3A and T30175 and (**B**) corresponding variants AID-1-G6T, -T12A and AIR-3A-G17U were incubated with increasing amounts (0--1μM) of Hyper-IL-6 (**A and B**). Filter retention assays with constant amounts (\< 1 nM) of ^32^P-radioactively labeled aptamers.](rna-10-216-g2){#F2}

The interaction between AID-1 and Hyper-IL-6 was further analyzed by surface plasmon resonance (SPR) measurements to define the association (*k*~on~) and dissociation rates (*k*~off~). Hyper-IL-6 was immobilized on spot-1 of a carboxymethylated sensor chip using EDC/NHS chemistry. Since IL-6 did not interact with the aptamers (see above), it was immobilized on spot-2 of the same sensor chip to serve as a control. The formation of AID-1/Hyper-IL-6 complexes was monitored as SPR signal given in response units (RU). For all sensorgram, background RUs from control spot-2 were subtracted from signals on spot-1. As shown in [**Figure S3**](#SUP1){ref-type="supplementary-material"}, the SPR signals of AID-1 binding to Hyper-IL-6 increased in a concentration dependent manner. Furthermore, the aptamer showed a rapid association and a rapid dissociation as well. The dissociation rate constant (*k*~off~) and association rate constant (*k*~on~) were determined to be 4.2 × 10^−2^ M^−1^s^−1^ and 1.5 × 10^4^ M^−1^s^−1^, respectively. AID-1 bound Hyper-IL-6 with a *K*~d~ of 490 nM and the *K*~d~ determination using SPR and FRA yielded in comparable results.

Hyper-IL-6 binding was also analyzed with variants comprising the repetitive motifs d(GGT)~4~ and d(GGGGT)~4~ as well as with the TBA which solely consists of desoxy guanosines and thymidines. In all cases only AID-1 significantly bound to Hyper-IL-6 ([**Fig. S4**](#SUP1){ref-type="supplementary-material"}).

Due to the fact that structural stability of AID-1 is highly dependent on the presence of monovalent cations[@R41] binding was analyzed in selection buffer as well as in Tris buffer with the addition of potassium or sodium, respectively ([Fig. 3](#F3){ref-type="fig"}). Binding to Hyper-IL-6 occurred in all three buffers. But differences regarding proportion of binding could be detected in the buffer containing sodium. As it is known that sodium does not stabilize quadruplex structure as good as potassium we concluded that Hyper-IL-6 binding is dependent on structural stability.

![**Figure 3.** Influence of different monovalent cations on Hyper-IL-6 binding. FRA were performed in presence of selection buffer (3 mM MgCl~2~ in PBS) and Tris buffer (20 mM pH 7.4) with addition of potassium (100 mM KCl) or sodium (100 mM NaCl), respectively. Filter retention assays with constant amounts (\< 1 nM) of ^32^P-radioactively Flabelled aptamers.](rna-10-216-g3){#F3}

Affinity of AID-1 variants for Hyper-IL-6
-----------------------------------------

The binding of AID-1 variants was measured by FRA in order to identify sites as important for Hyper-IL-6 binding ([Fig. 2](#F2){ref-type="fig"} **and** [Table 2](#T2){ref-type="table"}). AID-1-T, a variant omitting the 3′-terminal thymidine (T16), revealed a dissociation constant of 127 nM being similar to that of AID-1. To analyze whether the other remaining thymidine nucleotides were necessary for Hyper-IL-6 binding, each thymidine was individually replaced by adenosine (AID-1-T4A, -T8A, -T12A, -T16A). Furthermore, all thymidine nucleotides were replaced simultaneously by adenosine yielding AID-1+A. T8A and T12A exchanges had no influence on Hyper-IL-6 binding compared with AID-1 ([Table 2](#T2){ref-type="table"} **and** [Fig. 2B](#F2){ref-type="fig"}). Variants T4A and T16A, however, showed reduced affinity and AID-1+A barely bound Hyper-IL-6 ([Table 2](#T2){ref-type="table"}). We then examined the influence of single guanosine to thymidine exchanges within the first G-triplet (AID-1-G1T, -G2T, -G3T). Additionally, four variants were tested in which the first guanine of each of the four remaining G-tetrads was replaced simultaneously (PolyGT) or individually (AID-1-G6T, -G10T, -G14T). Finally, the guanosines of the central tetrad were replaced by adenosines (AID-1-G6A, AID-1-G6A/G14A). FRA showed that all guanosine replacements resulted in a complete loss of Hyper-IL-6 binding activity ([Table 2](#T2){ref-type="table"}).

###### **Table 2.** DNA and RNA aptamers as well as their variants with affinity for Hyper-IL-6 are affected regarding quadruplex structure

  -------------------------------------------------------------------------------------------------------------
  Oligomers            Sequence (5′-3′)                      Binding to Hyper-IL-6\   CD signal^a^   *T*~m~\
                                                             *K*~d~ \[nM\]                           \[°C\]
  -------------------- ------------------------------------- ------------------------ -------------- ----------
  **AID-1**            d(GGGTGGGTGGGTGGGT)                   209 ± 96                 1              \> 85

  **AID-1-T**          d(GGGTGGGTGGGTGGG)                    127 ± 79                 1.8            \> 85

  **AID-1-G1T**        d(**T**GGTGGGTGGGTGGGT)               n.d.^b^                  0.6            30

  **AID-1-G2T**        d(G**T**GTGGGTGGGTGGGT)               n.d.                     0.7            \< 20

  **AID-1-G3T**        d(GG**T**TGGGTGGGTGGGT)               n.d.                     0.6            35

  **AID-1-G6T**        d(GGGTG**T**GTGGGTGGGT)               n.d.                     0.7            \< 20

  **AID-1-G10T**       d(GGGTGGGTG**T**GTGGGT)               n.d.                     0.6            \< 20

  **AID-1-G14T**       d(GGGTGGGTGGGTG**T**GT)               n.d.                     0.6            \< 20

  **AID-1-G6A**        d(GGGTG**A**GTGGGTGGGT)               n.d.                     0.7            \< 20

  **AID-1-G6A/G14A**   d(GGGTG**A**GTGGGTG**A**GT)           n.d.                     0.2            \< 20

  **AID-1-T4A**        d(GGG**A**GGGTGGGTGGGT)               420 ± 160                1.4            76

  **AID-1-T8A**        d(GGGTGGG**A**GGGTGGGT)               316 ± 59                 1.6            74

  **AID-1-T12A**       d(GGGTGGGTGGG**A**GGGT)               234 ± 71                 1.3            77

  **AID-1-T16A**       d(GGGTGGGTGGGTGGG**A**)               693 ± 392                1.3            \> 80

  **AID-1+A**          d(GGG**A**GGG**A**GGG**A**GGG**A**)   691 ± 271                1.6            61

  **PolyGT**           d(G**T**GTG**T**GTG**T**GTG**T**GT)   n.d.                     0.1            \< 20

  **NK3**              d(G**TT**TG**T**GT**TT**GTG**T**GT)   n.d.                     0.1            \< 20

  **T30175**           d(GTGGTGGGTGGGTGGGT)                  293 ± 94                 0.9            62

  **d(GGT)~4~**        d(GGTGGTGGTGGT)                       n.d.                     0.4            n.d.

  **d(GGGGT)~4~**      d(GGGGTGGGGTGGGGTGGGGT)               n.d.                     1.8            71

  **TBA**              d(GGTTGGTGTGGTTGG)                    n.d.                     -0.2^c^        41

  **rAID-1**           r(GGGUGGGUGGGUGGGU)                   208 ± 53                 1              \> 85

  **rAID-1-U**         r(GGGUGGGUGGGUGGG)                    199 ± 65                 1.5            n.s. ^d^

  **rAID-1-G6U**       r(GGGUG**U**GUGGGUGGGU)               n.d.                     0.7            n.s.

  **AIR-3A**           r(GGGGAGGCUGUGGUGAGGG)                82 ± 9                   0.8            48

  **AIR-3A-G17U**      r(GGGGAGGCUGUGGUGA**U**GG)            n.d.                     0.5            \< 20

  **AIR-3A-G17/18U**   r(GGGGAGGCUGUGGUGA**UU**G)            n.d.                     0.5            \< 20
  -------------------------------------------------------------------------------------------------------------

^a^ Relative ellipticity at 265 nm with respect to AID-1 or rAID-1, respectively; ^b^n.d. = not detectable; ^c^anti-parallel-stranded quadruplex; ^d^n.s. = not specified. *K*~d~ values were determined by FRA. Quadruplex structure stability was studied by CD spectroscopy and thermal stability analysis. CD signals at 265 nm are listed and reduced CD signals as well as reduced *T*~m~ values indicate a less pronounced quadruplex structure. CD signals are presented as relative values to AID-1 ( = 1) and rAID-1 ( = 1), respectively. Deletions or substitutions of nucleotides are pointed out in bold.

The RNA counterpart \[r(GGGU)~4~\] of AID-1, which we refer to as rAID-1, was tested with respect to Hyper-IL-6 affinity. The measured binding (*K*~d~ = 208 nM) was similar to that of AID-1 ([Fig. 2A](#F2){ref-type="fig"}). More rAID-1 variants were then analyzed. The deletion of the uracil nucleotide at the 3′-end (rAID-1-U) did not impair binding ability to Hyper-IL-6 (*K*~d~ = 199 nM). Further single guanosine transversions within the central tetrad (rAID-1-G2U, -G6U, -G10U, -G14U), however, caused losses in binding capabilities ([Table 2](#T2){ref-type="table"}).

AID-1, here selected as an IL-6R DNA aptamer turned out to be identical to the known HIV inhibitor T30923.[@R42] Another HIV-1 inhibitor, T30175, with a similar sequence (5′-GTGGTGGGTGGGTGGGT-3′) was analyzed with respect to its binding behavior to Hyper-IL-6 via FRA. T30175 differs in only one additional thymidine nucleotide at position two.[@R43] FRA revealed that T30175 also bound Hyper-IL-6 (*K*~d~ = 293 nM, [Table 2](#T2){ref-type="table"} **and** [Fig. 2A](#F2){ref-type="fig"}), but not the cytokine IL-6 itself indicating its affinity for IL-6R ([**Fig. S5**](#SUP1){ref-type="supplementary-material"}).

Structural analyses of AID-1 and its variants via circular dichroism (CD) and thermal stability experiments
-----------------------------------------------------------------------------------------------------------

d(GGGT)~4~ or AID-1 as well as rAID-1, AIR-3A and T30175 have already been shown to exhibit an intrinsic all-parallel G-quadruplex. G-quadruplex formation and thermal stability could be demonstrated by CD spectroscopic analyses and stability tests.[@R15]^,^[@R20]^,^[@R21]^,^[@R44] The stability of all these quadruplexes was dependent on the presence of monovalent cations. Furthermore, a preference was observed at which potassium ions were favored over sodium ions.

To elucidate the correlation between structural stability and sequence in relation to their functionality, AID-1 variants were analyzed and compared concerning CD spectra and *T*~m~ values. All data are summarized in ([Table 2](#T2){ref-type="table"}).

The AID-1 aptamer variant AID-1-T showed a significantly increased CD signal at 265 nm ([Fig. 4A](#F4){ref-type="fig"}) and retained a *T*~m~ value of \> 85°C ([Fig. 4C](#F4){ref-type="fig"} **and** [Table 2](#T2){ref-type="table"}). Thus, removal of 3′ thymine (T16) did not destabilize quadruplex formation.[@R21] Aptamer variants with a thymine nucleotide replaced by adenine (AID-1-T4A, -T8A, -T12A, -T16A, AID-1+A) showed CD spectra characteristic of quadruplex structure with signal strengths comparable to AID-1 (T12A: [Fig. 4C](#F4){ref-type="fig"}) *T*~m~ values were slightly reduced (61--80°C). Replacing single deoxy guanosine nucleotides by adenine or thymine nucleotides within the G-tetrad (AID-1-G1T, -G2T, -G3T, -G6T, -G6A -G10T, -G14T) led to destabilization of the quadruplex structure, which could be observed by a reduced CD signal at 265 nm and a significant reduction of *T*~m~ values to below 30°C. Furthermore, replacing two desoxy guanosine nucleotides simultaneously (AID-1-G6A/G14A: [Fig. 4B](#F4){ref-type="fig"}) or rather all guanines of the central tetrads by thymidines (PolyGT) led to total loss of quadruplex characteristics in the CD spectra. r(GGGU)~4~ or rAID-1 was previously described as a quadruplex forming oligonucleotide.[@R44] This was verified by CD profiles ([Fig. 4A](#F4){ref-type="fig"}) and melting point determination ([Fig. 4C](#F4){ref-type="fig"} **and** [Table 1](#T1){ref-type="table"}; *T*~m~ \> 85°C), which displayed a hypochromic effect typical of parallel quadruplex structure. CD spectra of rAID-1 variants containing a single guanosine transversion within the central tetrad (rAID-1-G6U, -G10U, -G14U) did not significantly change compared with rAID-1 ([Table 2](#T2){ref-type="table"}). The dependence of quadruplex formation on monovalent cations was also analyzed by CD spectroscopy in PBS or 50 mM Tris buffer in the absence and presence of 100 mM KCl or 100 mM NaCl, respectively ([**Fig. S6**](#SUP1){ref-type="supplementary-material"}). The 265 nm signals for rAID-1 plus the variants rAID-1-U and rAID-1-G6U decreased in a buffer dependent manner: PBS \> 50 mM Tris, 100 mM KCl \> 50 mM Tris, 100 mM NaCl \> 50 mM Tris. These findings indicate a higher stability in the presence of K^+^ ions compared with Na^+^ ions. However, the absence of monovalent cations led to complete loss of structure stability. These findings are in accordance with structural stabilities of AID-1.

![**Figure 4.** IL-6R aptamer modifications affecting quadruplex structure. (**A and B**) CD spectroscopic analyses in PBS and (**C and D**) melting curves of AID-1, its variants AID-1-T, -G6T, -G6A/G14A, -T12A and the RNA counterpart rAID-1.](rna-10-216-g4){#F4}

MD-simulations to test 3D-structure of selected aptamers
--------------------------------------------------------

One might expect modeling and simulation to show a structural basis for measured differences in binding affinity. The simulation results, however, were dominated by a different result. Weak binding seemed to reflect poor stability of the quadruplex. To estimate this properly, one would need many folding/unfolding events in the simulations, but this will rarely be observable on the timescale of molecular dynamics simulations. One can obtain a less quantitative estimate from the apparent tendency of the molecule to open and drift away from the initial coordinates. This is best measured with a sliding window approach, continuously measuring the drift. To this end, each snapshot was compared with its counterpart, 2.5 ns earlier in the simulation.

Given this measure, there is no evidence of instability for AID-1 ([**Fig. S7**](#SUP1){ref-type="supplementary-material"}) nor any of the close sequence related variants: AID-1-G2T, -G6T, -G6A, -G10T or -G14T (AID-1-G6T see [**Fig. S7**](#SUP1){ref-type="supplementary-material"}). Both the sliding window and absolute rmsd values remain small and comparable with those of AID-1 (0.14 Å ± 0.1). In contrast, variants with several modifications such as PolyGT and NK3 showed significantly increased rmsd values in comparison to AID-1 indicating loss of 3D-stucture ([Fig. 5B](#F5){ref-type="fig"}; [**Fig. S7**](#SUP1){ref-type="supplementary-material"}).

![**Figure 5.** Structures of IL-6R aptamer rAID-1 (**A**) and control aptamer NK3 (**B**) after 35 ns of MD simulation. RNA counterpart of AID-1 (rAID-1; (**A**). Guanine bases are shown in green, thymine/uracil bases in blue and complexing potassium ions in purple.](rna-10-216-g5){#F5}

We also wanted to verify the quadruplex structure of the rAID-1, the RNA counterpart, using MD simulations. The structure of the DNA aptamer AID-1 served as a template for the initial model. Again, the MD simulation of the RNA aptamer r(GGGU)~4~ was completely stable over the 35 ns simulation ([Fig. 5A](#F5){ref-type="fig"}; [**Fig. S7**](#SUP1){ref-type="supplementary-material"}). Although the simulation shows motions such as the peak around 9 ns ([**Fig. S4A**](#SUP1){ref-type="supplementary-material"}), the rmsd value in the simulations never rose above 1.2 Å which is even smaller than in the calculations for AID-1. In this particular calculation, one can even explain the major motion. It was due to the 3′-terminal uracil residue detaching itself from the G-quadruplex, which did not disturb the overall structural stability.

Affinity of IL-6R aptamers for HIV-1 integrase and their inhibitory effect on 3′ processing activity in vitro
-------------------------------------------------------------------------------------------------------------

To investigate the affinity of IL-6R aptamers as well as their variants for HIV-1 integrase and their possible inhibitory effects on integrase activity, corresponding FRAs and activity assays were performed. AID-1 and its variants AID-1-G6T and AID-1-T12A bound HIV-1 integrase with affinities in the nanomolar range (*K*~d~ values 144 nM, 129 nM and 142 nM, respectively; [Fig. 6A](#F6){ref-type="fig"}). AID-1 and AID-1-T12A aptamers showed the same quadruplex structure, but AID-1-G6T showed destabilized structures with *T*~m~ values \< 20°C ([Fig. 4B](#F4){ref-type="fig"} **and**[Table 2](#T2){ref-type="table"}). For this reason a variant, AID-1-G6A/G14A, that showed significantly reduced quadruplex structure ([Fig. 4B](#F4){ref-type="fig"}), was analyzed. Despite structural instabilities from CD spectroscopy, AID-1-G6A/G14A bound HIV-1 integrase with a comparable affinity to AID-1 \[d(GGGT)~4~\] with a *K*~d~ value of 381 nM ([Fig. 6A](#F6){ref-type="fig"}). Additionally, we could demonstrate that the IL-6R RNA aptamer rAID-1 as well as the previously described IL-6R RNA aptamer, AIR-3A,[@R15] and its variant AIR-3A-G17U, which had lost its affinity for IL-6R, still possessed affinity for HIV-1 integrase with *K*~d~ values of 151 nM, 20 nM and 8 nM, respectively ([Fig. 6F](#F6){ref-type="fig"}**and**[Table 3](#T3){ref-type="table"}). All of the tested IL-6R DNA and RNA aptamers as well as their corresponding variants showed comparably high affinities for HIV-1 integrase.

![**Figure 6.** 3′ processing activity of HIV-1 integrase and its inhibition by IL-6R aptamers. (**A and B**) DNA, RNA aptamers as well as corresponding variants were incubated with increasing amounts (0--1 μM) of HIV-1 integrase. Binding was detected by using FRA with constant amounts (\< 1 nM) of ^32^P-radioactively labeled aptamers. (**C**) Short oligonucleotides derived from U5 long-terminal repeat DNA ends were used to study 3′ processing activity. For this purpose a 21-mer (ODN70) was radiolabelled with ^32^P and hybridized to its complementary strand (AE117). ODN70 was converted into a 19-mer oligonucleotide by HIV-1 integrase. (**D**) Gel electrophoresis of reaction was monitored in the presence of increasing amounts (5--1230 nM) inhibiting AID-1 or its variant AID-1-G6T. (**E and F**) Graph of concentration dependant inhibition of 3′ processing activity.](rna-10-216-g6){#F6}

###### **Table 3.** Aptamers with affinity for HIV-1 integrase as well as their inhibitory effect on HIV-1 integrase 3′ processing activity in vitro

  Oligomers            HIV-1 integrase   
  -------------------- ----------------- ----------
  **T30175**           15 ± 8            37
  **AID-1**            144 ± 54          115
  **AID-1-G6T**        129 ± 68          495
  **AID-1-T12A**       140 ± 50          206
  **AID-1-G6A/G14A**   381 ± 244         n.d. ^b^
  **rAID-1**           151 ± 32          49
  **AIR-3A**           20 ± 6            74
  **AIR-3A-G17U**      8 ± 4             149

^a^*K*~d~ and *IC*~50~ values were determined based on FRA and HIV-1 integrase activity, respectively. ^b^n.d. = not detectable

Next, we wanted to see whether HIV-1 integrase binding led to inhibition of HIV-1 integrase activity in vitro. Therefore, we performed activity assays of HIV-1 integrase in the presence of selected DNA or RNA molecules as previously described.[@R31]^,^[@R32] To investigate 3′ processing activity, a radioactively labeled double-stranded DNA served as substrate. During 3′ processing, a dinucleotide is cleaved off from the substrate ([Fig. 6C](#F6){ref-type="fig"}). Efficiency of the reaction could be monitored by gel electrophoresis ([Fig. 6D](#F6){ref-type="fig"}) and the presence of aptamer led to concentration dependent inhibition of HIV-1 integrase activity. We observed that all aptamers that bound to HIV-1 integrase also influenced its 3′ processing activity in a concentration dependent manner ([Fig. 6E](#F6){ref-type="fig"}**and**F). Only the AID-1 variant AID-1-G6A/G14A, which was known to have less quadruplex structure, did not inhibit 3′ processing. However compared with AID-1, the variant AID-1-G6T that had lost the ability to bind IL-6R, inhibited HIV-1 integrase with a 4-fold reduced *IC*~50~ value of 0.5 mM ([Fig. 6E](#F6){ref-type="fig"}). AID-1-T12A - still binding to IL-6R - also served as HIV-1 integrase inhibitor comprising an *IC*~50~ value of 206 nM ([Fig. 6E](#F6){ref-type="fig"} **and** [Table 3](#T3){ref-type="table"}).

In addition, the inhibitory effects of the RNA aptamer rAID-1 (the corresponding RNA variant of AID-1) and AIR-3A were analyzed and also turned out to inhibit the 3′ processing activity of HIV-1 integrase with *IC*~50~ values of 49 nM and 74 nM, respectively ([Fig. 6F](#F6){ref-type="fig"}). Variants of AIR-3A termed AIR-3A-G17U and AIR-3A-G17/18U, which did not bind the IL-6R showed three times higher *IC*~50~ values (149 nM and 193 nM, respectively) in comparison to that of AIR-3A ([Fig. 6F](#F6){ref-type="fig"} **and** [Table 3](#T3){ref-type="table"}).

To find a possible explanation for the binding of the aptamers to the different proteins, the structures of IL-6R[@R45] and HIV-1[@R46] were compared using three programs that detect similarities at the structural level, even without sequence similarity. Neither Salami,[@R38] Dali[@R39] nor FATCAT[@R40] reported any significant structural similarity.

IL-6R aptamers inhibit HIV infection
------------------------------------

AID-1 or T30923 and T30175 are well established HIV infection inhibitors.[@R17]^,^[@R20] For this reason we analyzed AID-1, T30175 and in addition the IL-6R aptamers rAID-1 and AIR-3A as well as their respective variants (AID-1-G6T, AID-1-G6A/G14A, AIR-3A-G17/18U) for their ability to inhibit HIV de novo infection. For infection of TZM-bl cells,[@R33] we used the CXCR4-tropic HIV-1 strain NL4/3. Effective infection of TZM-bl cells resulted in activation of HIV-1 long-terminal repeat (LTR) promoter-driven luciferase reporter gene expression. The presence of aptamers during infection process caused a concentration-dependent inhibition of HIV infection, which was detected via reduced luciferase activity ([Fig. 7A--C](#F7){ref-type="fig"}). All IL-6R aptamers inhibited HIV infection efficiently at a concentration of 1 µM with exception of the AID-1 variant AID-1-G6A/G14A ([Fig. 7A](#F7){ref-type="fig"}: black bars). Again we could show that aptamer activity is strongly related to its structure. Based on our data, *EC*~50~ values could be calculated ([Table 4](#T4){ref-type="table"}) and showed that the RNA aptamers rAID-1 and AIR-3A inhibited HIV infection as efficiently as the known inhibitors AID-1 and T30175 with *EC*~50~ values of 96 and 56 nM, respectively. We also observed that variants with destabilized quadruplex structure inhibited 3-fold (AID-1-G6T) or 95-fold (AID-1-G6A/G14A) less efficiently than the original aptamer.

![**Figure 7.** IL-6R aptamers inhibit efficient HIV infection. (**A**) TZM-bl cells were infected by a CXCR4-tropic HI virus (NL4/3; black bars) or a VSV-G pseudotyped HI virus (white bars) in presence of 1 μM IL-6R aptamer. (**B and C**) Aptamers or it variants prevented TZM-bl cells from NL4/3 infection, dependent on concentration (16 nM--10 μM). Effective infection was observed by increasing luciferase activity. (**D and E**) IL-6R DNA and RNA aptamers as well as their variants were incubated with increasing amounts of HIV gp120 (0--1 μM). Binding was detected by FRA using constant amounts (\< 1 nM) of ^32^P-radioactively labeled aptamers.](rna-10-216-g7){#F7}

###### **Table 4.** Aptamers inhibiting HIV infection by binding HIV gp120

  Oligomers            HIV infection   HIV gp120 binding   
  -------------------- --------------- ------------------- ----------
  **T30175**           56 ± 15         201 ± 111           20 ± 4
  **AID-1**            96 ± 34         775 ± 162           17 ± 2
  **AID-1-G6T**        313 ± 20        n.s.^a^             n.s.
  **AID-1-G6A/G14A**   9120 ± 11       440 ± 60            10 ± 1
  **rAID-1**           45 ± 17         430 ± 220           42 ± 10
  **AIR-3A**           29 ± 10         227 ± 58            100 ± 11
  **AIR-3A-G17/18U**   80 ± 9          230 ± 98            100 ± 17

^a^ n.s. = not specified. *K*~d~ and *EC*~50~ values were determined based on FRA and inhibition of infection of TZM-bl cells by NL4/3, respectively.

To exclude a toxic influence of aptamers during infection, cell viability was investigated in parallel. IL-6R aptamers as well as the known HIV inhibitor T30175 did not affect cell proliferation (data not shown).

Next we wanted to determine if IL-6R aptamers inhibit HIV infection by blocking interaction with gp120-CD4 as previously described for Zintevir.[@R23] Therefore, VSV-G pseudotyped HIV-1, lacking the viral envelope proteins, was used for de novo infection experiments. VSV-G pseudotyped virus infected TZM-bl cells by endocytosis independently of gp120. The presence of 1 µM IL-6R aptamer or respective variants did not prevent TZM-bl cells from infection by VSV-G pseudotyped HIV ([Fig. 7A](#F7){ref-type="fig"}, white bars). This led to the conclusion that IL-6R aptamers inhibited HIV infection by interfering with the gp120-CD4 interaction. To confirm this, FRA with HIV gp120 was performed. All aptamers bound gp120, although differences were observed regarding binding amplitude. The DNA aptamers T30175 and AID-1 achieved a maximum of binding of 20%, the variant AID-1-G6A/G14A only 5% which showed least inhibitory effect on HIV infection. The RNA aptamer AIR-3A as well as its variant AIR-3A-G17/18U were completely bound of the protein and their *K*~d~ values were equal. Both inhibited HIV infection with same efficiency.

Discussion
==========

The IL-6 receptor aptamer AID-1 and the HIV inhibitor T30923 exhibit the identical sequence, d(GGGT)4
-----------------------------------------------------------------------------------------------------

We here report about the selection of a collection of aptamers with high affinities for the IL-6 receptor. One of those selected IL-6R aptamers, d(GGGT)~4~ also termed AID-1, exhibited a sequence identical to that of an already known HIV inhibitor, known as T30923.[@R42] This derivative of Zintevir ( = T30177) interferes with HIV infection in cell culture and inhibits HIV-1 integrase.[@R17] We could demonstrate that AID-1 bound IL-6R with a *K*~d~ value in the nanomolar range and that it was not competing with the cytokine IL-6 for IL-6R or the signal transducer gp130.

To delineate which single nucleotides of AID-1 are important for IL-6R binding or its structural stability, we also analyzed variants with guanine or thymine nucleotides replaced by thymine or adenine nucleotides, respectively. Regarding IL-6R binding we identified AID-1 variants possessing thymine transversions that were tolerated. In contrast, guanine transversions or transitions were not tolerated at all ([Table 2](#T2){ref-type="table"}).

Due to the fact that the selected IL-6R aptamer had an identical sequence as an HIV inhibitor, we analyzed other HIV inhibitors for IL-6R binding that had parallel stranded quadruplex structure in common. We found that the published HIV inhibitor T30175 with an additional thymine nucleotide at position two (compared with AID-1) was also able to bind IL-6R in a nanomolar range. But d(GGGGT)~4~ with proven inhibitory effect on HIV integrase activity[@R20] did not bind IL-6R. Consequently, an additional thymine nucleotide at position two was tolerated for IL-6R binding, but an additional guanine tetrad was not.

Variant analyses revealed that aptamer binding coincided with quadruplex structure formation
--------------------------------------------------------------------------------------------

CD spectroscopy, thermal stability tests and simulations showed that most of the AID-1 variations led to a destabilization or destruction of the quadruplex structure. Both, data from CD spectra and the hypochromic effect seen in melting analyses provided strong evidence for quadruplex structures. Although CD spectra of the variants with single guanines replaced suggested quadruplex structure, the reduced signals at 265 nm, melting behavior and changes of *T*~m~ values unequivocally confirmed quadruplex destabilization. More than one guanine replacement, however, led to significantly differing CD spectra.

The MD simulations supported the interpretation of many results in terms of stability, although they are less conclusive than spectroscopy. Only the most destabilizing variants (Poly-GT and NK3) were clearly recognized as unstable.

The DNA aptamer AID-1 and its RNA version rAID-1 exhibit equal structure and function
-------------------------------------------------------------------------------------

Comparing the aptamers AID-1 and rAID-1, it seems that most results from DNA apply to the RNA analog. CD spectroscopy and thermal stability measurements confirmed a parallel-stranded quadruplex structure for rAID-1 that was stabilized by monovalent cations with a possible preference for K^+^ over Na^+^ ions. The findings agree with results of Joachimi et al.[@R44] who compared quadruplex forming DNAs with corresponding RNAs and demonstrated that RNA variants of all-parallel DNA quadruplexes possess the same structures and similar thermal stabilities. The MD simulations showed no differences in stability and the binding measurements showed that rAID-1 is an IL-6R aptamer with affinity as strong as AID-1. Performing the same guanine transversions on rAID-1 and AID-1 led to a similar loss of IL-6R binding. The findings demonstrate that, contrary to general opinion, function and hence tertiary structure of DNA can be completely fulfilled by its RNA analog, which so far, was only reported twice.[@R47]^,^[@R48]

Quadruplex structure also is a prerequisit for effective HIV inhibition
-----------------------------------------------------------------------

To identify aptamer variants with either affinity for IL-6R or HIV integrase, we investigated the binding behavior of the already mentioned variants to HIV-1 integrase and their capacity to inhibit its 3′ processing activity in vitro. We could clearly reproduce such an inhibitory effect of AID-1[@R42] with an *IC*~50~ value in the nanomolar range. Additionally IL-6R binding aptamers (rAID-1, AIR-3A) and their variants also showed an inhibitory effect. Differences in inhibition effects, however, could be observed between variants that did bind the IL-6R (AID-1-T12A) and variants that did not (AID-1-G6T, -G6A/G14A, AIR-3A-G17U, -G17/18U). Variants with at least one guanine nucleotide exchange and corresponding structural instabilities lost their affinity for the IL-6R and also exhibited a less inhibitory effect on HIV-1 integrase. These findings indicate that aptamer-protein-interaction is highly associated with stable G-quadruplex formation, which comprises the binding scaffold. Jing et al.[@R42] already demonstrated for 21 derivatives of AID-1 that there was a functional correlation between thermal stability and the ability to inhibit HIV-1 integrase activity.

In our study, aptamer variants that either bound IL-6R or inhibited HIV-1 integrase could not be identified, probably due to the fact, that quadruplex structure is required for the interaction with both proteins.

Furthermore, it should be mentioned that intrinsic all-parallel quadruplexes inhibit HIV-1 integrase activity in vitro as demonstrated for AID-1, T30175 and d(GGGGT)~4~[@R20]^,^[@R21]^,^[@R43] and revealed here for rAID-1 and AIR-3A as well. In contrast, TBA comprising an anti-parallel quadruplex structure did not inhibit HIV-1 integrase.[@R17]

Structural comparison of IL-6R and HIV integrase did not lead to an explanation for aptamer binding to the two targets
----------------------------------------------------------------------------------------------------------------------

Since IL-6R-binding aptamers inhibit HIV-1 integrase in vivo, one might expect some similarity between the protein targets, but this is not the case. Not only is there no significant sequence similarity, but none of the three programs which look for structural similarity could generate a structural superposition. There are two possible explanations. First, the two different protein folds could still present functional groups in similar orientations in space, albeit from different scaffolds. Second, it is possible that the proteins bind to different sites on the aptamers and there is no similarity in binding modes. Ultimately, this kind of structural question will only be answered by studies of the aptamer-protein complexes.

IL-6R RNA aptamers inhibited HIV infection as effective as T30175
-----------------------------------------------------------------

It has been reported that T30175 is an efficient HIV inhibitor.[@R17] This work showed that the IL-6R RNA aptamers rAID-1 and AIR-3A are also effective inhibitors of HIV infection and the inhibition seems to be very dependent on quadruplex formation.

T30175 interferes with CD4/gp120 interactions by binding to HIV gp120.[@R23] The results here showed that IL-6R aptamers AID-1, rAID-1 and AIR-3A were not able to inhibit HIV infection if gp120 was absent. This suggests that IL-6R aptamers inhibit HIV infections in a manner similar to T30175.

Outlook
-------

The correlation between IL-6R binding and HIV-1 integrase inhibition of the selected aptamers remains unclear. Although many HIV integrase-inhibiting oligonucleotides have been described, their mode of action is not completely understood. Remarkably, cells that are infected with HIV express higher amounts of IL-6R on their cell surfaces or release increased amounts of soluble IL-6R.[@R49]^,^[@R50] Considering that IL-6R aptamers can be internalized,[@R15]^,^[@R51] a new inhibitory mechanism for these HIV inhibitors could be postulated. The inhibitors might enter the cell via IL-6R-mediated internalization and target HIV-1 integrase inside the cell. Whether this hypothesis holds and whether all IL-6R aptamers also inhibit HIV infection in vivo will have to be investigated in future experiments. Accompanying structural investigations are under way.

Materials and Methods
=====================

Chemicals and buffers
---------------------

Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich and oligonucleotides from Invitrogen.

Proteins
--------

All standard enzymes for molecular biology were obtained from Fermentas, hIL-6 from Merck, HIV-1 integrase from Biocat, HIV gp120, Thrombin from CellSystems, Lysozyme from Carl Roth. T7 RNA polymerase,[@R25] sIL-6R[@R26] and Hyper-IL-6[@R27] were isolated from recombinant overproducers as described.

In vitro selection of DNA aptamers
----------------------------------

SELEX was performed as previously described.[@R1] The soluble part of the IL-6 receptor (sIL-6R) was biotinylated using EZ-Link Sulfo-NHS-LC-Biotin reagent (Thermo Fisher Scientific) and coupled to streptavidin-coated magnetic beads (Dynabeads M-280; Thermo Fisher Scientific).[@R28] The SELEX process was initiated by incubation of the DNA library D1 (5′-GCCTGTTGTGAGCCTCCTAAC-N~60~-CATGCTTATTCTTGTCTCCC-3′, 500 pmol, 3 × 10^14^ individual molecules) with sIL-6R immobilized on magnetic beads in selection buffer. After extensive washing, remaining DNAs were eluted by heating and amplified via PCR. After 13 SELEX rounds, the resulting dsDNA library was cloned into the vector pUC19. Individual clones were identified by DNA sequencing.[@R29]

Filter retention assay (FRA)
----------------------------

To analyze aptamer-protein interactions, DNA or RNA molecules were terminally radioactively labeled using T4 polynucleotide kinase and γ-\[^32^P\]-ATP (3000 Ci/mmol; Hartmann Analytic). To perform FRAs with Hyper-IL-6 or HIV gp120 the target protein was serially diluted (0--1 µM) in selection buffer (PBS, 3 mM MgCl~2~, pH 7.4). For FRAs with HIV-1 integrase, IN buffer (20 mM Hepes, pH 7.5, 10 mM DTT, 7.5 mM MnCl~2~, 10 mM NaCl, 0.05% \[v/v\] Nonidet P40) was used. After incubation of the protein with constant amounts of labeled nucleic acids (\< 0.5 nM) for 30 min at 37°C, samples were passed through a pre-equilibrated nitrocellulose membrane (0.45 µm, Carl Roth) using a vacuum manifold (Minifold I Dot-Blot-System; Schleicher and Schuell, VWR International). After washing twice with buffer, the membrane was dried, exposed to a phosphor-imaging screen (Bio-Rad). The retained radioactivity was quantified using Quantity One software (Bio-Rad).

Circular dichroism (CD) spectroscopy
------------------------------------

Quadruplex formation of nucleic acids was measured by CD spectroscopy[@R30] with a Spectrometer Model 215 (Aviv Biomedical). Samples were prepared with 5 µM DNA or RNA diluted in PBS or 50 mM TRIS-HCl, pH 7.4 in presence of 100 mM KCl or NaCl, respectively. Spectra were scanned twice from 200 to 320 nm at 25°C.

UV spectroscopy
---------------

For melting point (*T*~m~) determination aptamers (2.5 µM) were dissolved in 100 mM TRIS-HCl, pH 7.4 and 5 mM KCl. Measurements were performed with a Varian Cary Bio 300 UV-Visible Spectrophotometer. Aptamer solution was then transferred into a quartz cuvette (1-cm path length) and covered with mineral oil. Heating and subsequent cooling were performed in steps of 0.5°C min^−1^ between 20 and 85°C. Absorption was monitored at 295 nm. *T*~m~ values were calculated based on the van't Hoff equation.

HIV-1 integrase inhibiting assay
--------------------------------

Aptamer inhibition of 3′ processing activity of HIV-1 integrase was determined as previously described.[@R31]^,^[@R32] Oligonucleotides (ODN) derived from the U5 end of the HIV long-terminal repeat were the following: ODN70 d(GTGTGGAAAATCTCTAGCAGT), ODN71 d(GTGTGGAAAATCTCTAGCA)[@R31] and AE117 d(ACTGCTAGAGATTTTCCACAC).[@R32] ODN70 was radioactively labeled with T4 polynucleotide kinase and hybridized to AE117 after gel purification. As a control for 3′ processing, ODN71 was radiolabelled and hybridized to AE117 lacking two nucleotides at the 3′ end. For inhibition assays, 500 nM HIV-1 integrase and inhibitor were pre-incubated in reaction buffer (20 mM Hepes, pH 7.5, 5 mM DTT, 10 mM MgCl~2~, 75 mM NaCl, 15% DMSO, 5% PEG 8000) for 30 min at 37°C. Then 10 nM 5′ labeled substrate was added, followed by incubation for 30 min at 37°C. The reaction was stopped by adding 1/5 loading buffer \[95% (v/v) formamide, 20 mM EDTA, 0.005% (w/v) bromophenol blue\] and heat inactivation at 90°C for 10 min. Samples were loaded on a 15% (19:1) denaturing polyacrylamide gel. The degree of inhibition was calculated with 100 × \[1-(D-C)/(N-C)\] where C, N, and D were fractions of 3′ processing products for DNA alone (C), DNA with integrase (N) and in addition of inhibitor (D), respectively.

Inhibition of HIV infection
---------------------------

The CXCR4-tropic HIV strain NL4/3 or VSV-G pseudotyped HIV-1 was used for TZM-bl cell infection. TZM-bl cells are HeLa cell derivatives, which present CD4 as well as the essential co-receptors CCR5 and CXCR4. These cells also produce HIV-1 LTR-driven luciferase expression cassette.[@R33] To investigate inhibition of HIV infection, 100 µl media including 10^4^ TZM-bl cells were seeded into a 96 well plate. On the following day, medium was replaced with medium including different concentrations of aptamers. After incubation for 1 h, 80 µl of the medium was transferred into an extra well and 10 µl NL4/3 virus (1 ng/µl) were added to the cells. Cells were incubated for additional 6 h and, as a last step, previously transferred medium was added back to the cells. 48 h later, cell lysate luciferase activity was measured by Luciferase Assay System (Promega).

Cell viability assay
--------------------

Oxidative processes of vital cells were detected via reduction of AlarmaBlue reagent (AbD Serotec), resulting in a reduced substance with characteristic absorption (570/600 nm). The assay was performed in 96 well plates with 10^4^ cells in each 100 µl media. To detect proliferation, 20 µl AlarmaBlue reagent was added to each well, followed by 3 h of incubation.

Surface plasmon resonance
-------------------------

Aptamer-protein interactions were further analyzed by surface plasmon resonance (SPR) experiments using an SPR-2 Affinity Sensor (Sierra Sensors). A carboxymethylated sensor chip was pre-equilibrated with running buffer \[1 × selection buffer, 0.01% (v/v) Tween\] and activated by 0.1 M NHS (N-hydroxysuccinimide) and 0.4 M EDC \[N-ethyl-N′-(3-dimethylaminopropyl) carbodimide\] for the immobilization of the proteins on the chip surface. Hyper-IL-6 and IL-6, as a control, were immobilized on spot-1 and spot-2, respectively. After immobilization, non-reacted groups were inactivated by 1 M ethanolamine hydrochloride (pH 8.5). After generating a stable base line dilution, a series of nucleic acids were tested by injecting each over both spots. The protein surface was regenerated using 0.1 M NaOH followed by running buffer. Each signal from spot-2 was subtracted from the corresponding signal of spot-1, and the resulting curves were globally fitted to a 1:1 binding model using TraceDrawer software (Ridgeview Instruments).

Molecular dynamic simulations
-----------------------------

Initial coordinates were constructed by simple modeling with UCSF chimera[@R34] using a published structure as the template.[@R18] These coordinates were supported by NMR spectroscopy and appeared stable in MD simulations.[@R18] The system was prepared with *LEaP*[@R35] (neutralization; octahedral periodic boundary conditions) resulting in final systems with approximately 10,000 water molecules. GROMACS[@R36] with the *parmbsc0*[@R37] force field was used for energy minimization and all simulations. All other parameters were set to published values[@R18] to allow comparison with literature results. After initial energy minimisation (50,000 steps or gradient below 10^3^ kJ mol^−1^nm^−2^) each system was subjected to position-restrained simulation with harmonic restraints on all heavy atoms for 0.1 ns (time step 0.2 fs). This was followed by 35 ns MD simulation weakly coupled to a heat bath (t = 300 K, τ = 0.1 ps) that was used for analysis.

Structural comparison of proteins
---------------------------------

Structure searches for the non-sequence-related HIV-1 integrase (PDB acquisition codes 3LPT and 3LPU) and IL-6R (PDB 1N26) were performed with Salami,[@R38] Dali[@R39] and FATCAT.[@R40]
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